JP2010523096A5 - - Google Patents

Download PDF

Info

Publication number
JP2010523096A5
JP2010523096A5 JP2010501503A JP2010501503A JP2010523096A5 JP 2010523096 A5 JP2010523096 A5 JP 2010523096A5 JP 2010501503 A JP2010501503 A JP 2010501503A JP 2010501503 A JP2010501503 A JP 2010501503A JP 2010523096 A5 JP2010523096 A5 JP 2010523096A5
Authority
JP
Japan
Prior art keywords
seq
antibody
functional derivative
epcam
epcam antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010501503A
Other languages
English (en)
Japanese (ja)
Other versions
JP5631733B2 (ja
JP2010523096A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/053913 external-priority patent/WO2008122551A2/en
Publication of JP2010523096A publication Critical patent/JP2010523096A/ja
Publication of JP2010523096A5 publication Critical patent/JP2010523096A5/ja
Application granted granted Critical
Publication of JP5631733B2 publication Critical patent/JP5631733B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010501503A 2007-04-04 2008-04-02 抗EpCAM抗体およびその使用 Expired - Fee Related JP5631733B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07105628 2007-04-04
EP07105628.7 2007-04-04
PCT/EP2008/053913 WO2008122551A2 (en) 2007-04-04 2008-04-02 Anti-epcam antibody and uses thereof

Publications (3)

Publication Number Publication Date
JP2010523096A JP2010523096A (ja) 2010-07-15
JP2010523096A5 true JP2010523096A5 (https=) 2011-08-11
JP5631733B2 JP5631733B2 (ja) 2014-11-26

Family

ID=38458122

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010501503A Expired - Fee Related JP5631733B2 (ja) 2007-04-04 2008-04-02 抗EpCAM抗体およびその使用

Country Status (21)

Country Link
US (1) US8318911B2 (https=)
EP (1) EP2142570B1 (https=)
JP (1) JP5631733B2 (https=)
KR (1) KR101683884B1 (https=)
CN (1) CN101970497B (https=)
AT (1) ATE512988T1 (https=)
AU (1) AU2008235566B2 (https=)
BR (1) BRPI0810096A8 (https=)
CA (1) CA2682296C (https=)
CY (1) CY1111819T1 (https=)
DK (1) DK2142570T3 (https=)
EA (1) EA023679B1 (https=)
ES (1) ES2367675T3 (https=)
HR (1) HRP20110620T1 (https=)
IL (1) IL201196A0 (https=)
MX (1) MX2009010444A (https=)
PL (1) PL2142570T3 (https=)
PT (1) PT2142570E (https=)
RS (1) RS52040B (https=)
SI (1) SI2142570T1 (https=)
WO (1) WO2008122551A2 (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004068110A2 (en) 2003-01-24 2004-08-12 University Of Utah Methods of predicting mortality risk by determining telomere length
US9689028B2 (en) 2008-12-22 2017-06-27 University Of Utah Foundation Monochrome multiplex quantitative PCR
GB0909904D0 (en) * 2009-06-09 2009-07-22 Affitech As Product
JP6130307B2 (ja) 2011-03-17 2017-05-17 ザ ユニバーシティ オブ バーミンガム 再指向性免疫療法
WO2012158818A2 (en) * 2011-05-16 2012-11-22 Fabion Pharmaceuticals, Inc. Multi-specific fab fusion proteins and methods of use
CN103998932B (zh) 2011-06-29 2017-06-06 中央研究院 使用表面涂层对生物物质的捕获、纯化和释放
TWI485161B (zh) * 2012-03-02 2015-05-21 中央研究院 抗上皮細胞黏著分子(EpCAM)抗體及其使用方法
US9494500B2 (en) 2012-10-29 2016-11-15 Academia Sinica Collection and concentration system for biologic substance of interest and use thereof
EP2999800B1 (en) 2013-05-22 2019-09-25 Telomere Diagnostics Inc. Measures of short telomere abundance
WO2015153816A2 (en) 2014-04-01 2015-10-08 Academia Sinica Methods and systems for cancer diagnosis and prognosis
US10112198B2 (en) 2014-08-26 2018-10-30 Academia Sinica Collector architecture layout design
US9944978B2 (en) 2014-12-30 2018-04-17 Telomere Diagnostics, Inc. Multiplex quantitative PCR
US11098131B2 (en) 2015-07-31 2021-08-24 Sutro Biopharma, Inc. Anti-EpCAM antibodies, compositions comprising anti-EpCAM antibodies and methods of making and using anti-EpCAM antibodies
US10107726B2 (en) 2016-03-16 2018-10-23 Cellmax, Ltd. Collection of suspended cells using a transferable membrane
US11046782B2 (en) 2016-03-30 2021-06-29 Musc Foundation For Research Development Methods for treatment and diagnosis of cancer by targeting glycoprotein A repetitions predominant (GARP) and for providing effective immunotherapy alone or in combination
US20190262397A1 (en) 2016-07-26 2019-08-29 Tessa Therapeutics Pte. Ltd. Chimeric antigen receptor
WO2020018964A1 (en) 2018-07-20 2020-01-23 Fred Hutchinson Cancer Research Center Compositions and methods for controlled expression of antigen-specific receptors
EP3847196A4 (en) 2018-09-07 2023-01-04 ITabMed (HK) Limited BISPECIFIC ANTIGEN BINDING PROTEINS AND USES THEREOF
CA3120800A1 (en) 2018-12-17 2020-06-25 Revitope Limited Twin immune cell engager
WO2020132810A1 (en) 2018-12-24 2020-07-02 Generon (Shanghai) Corporation Ltd. Multispecific antigen binding proteins capable of binding cd19 and cd3, and use thereof
WO2020216210A1 (zh) * 2019-04-22 2020-10-29 江苏恒瑞医药股份有限公司 抗EpCAM抗体及其应用
AU2020292304B2 (en) 2019-06-11 2023-03-30 Bioatla, Inc. Conditionally active anti-EpCam antibodies, antibody fragments, their immunoconjugates and uses thereof
CN110950959B (zh) * 2020-02-25 2020-07-03 和铂医药(上海)有限责任公司 靶向EpCAM的抗体及其制备和应用
CN112094350B (zh) * 2020-06-01 2024-01-05 普众发现医药科技(上海)有限公司 可应用于肿瘤细胞捕获的小鼠抗细胞表面糖蛋白cd326的单克隆抗体
CN113527491B (zh) * 2020-08-19 2023-06-20 苏州易慕峰生物科技有限公司 人源化抗体、嵌合抗原受体、核酸、载体、细胞及应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675187A (en) 1983-05-16 1987-06-23 Bristol-Myers Company BBM-1675, a new antibiotic complex
US5525338A (en) 1992-08-21 1996-06-11 Immunomedics, Inc. Detection and therapy of lesions with biotin/avidin conjugates
IT1245748B (it) 1990-12-21 1994-10-14 Mini Ricerca Scient Tecnolog Preparazione includente anticorpi monoclonali biotinilati, avidina e biotina, per la diagnosi di affezioni tumorali e suo impiego
US5578287A (en) 1992-06-09 1996-11-26 Neorx Corporation Three-step pretargeting methods using improved biotin-active agent
JP3427871B2 (ja) * 1996-06-24 2003-07-22 戸田工業株式会社 コバルト被着型針状磁性酸化鉄粒子粉末
ITRM20010079A1 (it) 2001-02-16 2002-08-16 Sigma Tau Ind Farmaceuti Amminoderivati della biotina e loro coniugati con chelanti macrociclici.
US20050180979A1 (en) * 2004-02-13 2005-08-18 Micromet Ag Anti-EpCAM immunoglobulins
US7435804B2 (en) 2004-10-19 2008-10-14 Phage Biotechnology, Inc. Method for obtaining single chain antibodies to human interferon α2b

Similar Documents

Publication Publication Date Title
JP2010523096A5 (https=)
HRP20110620T1 (hr) PROTUTIJELO PROTIV EpCAM I NJEGOVE UPOTREBE
JP7209464B2 (ja) ヒトインターロイキン-2に対する免疫刺激性モノクローナル抗体
RU2014149332A (ru) Антитела против клаудина 18.2 для диагностики рака
JP2021514664A5 (https=)
JP2019534034A5 (https=)
JP2007526233A5 (https=)
JP2009517057A5 (https=)
JP2021500916A5 (https=)
JP2018504105A5 (https=)
RU2016104057A (ru) Новые белки, специфично связывающиеся с двумя мишенями -dll4 и vegf-, и их применение
JP2017538439A5 (https=)
RU2013125306A (ru) Связывающие протеины, специфичные по отношению к инсулин-подобным факторам роста, и их использование
JP2019502405A5 (https=)
JP2005538701A5 (https=)
IL273196B1 (en) Claudin 6 antibodies and methods of cancer treatment
JP2006507013A5 (https=)
JP2010510809A5 (https=)
RU2015142815A (ru) Лечение рака с использованием антител, связывающихся с поверхностным grp78
CN114667296B (zh) 一种双特异性抗体及其用途
JP2005528914A5 (https=)
RU2009137784A (ru) Человеческое опухолеспецифическое моноклональное антитело
CN112513094A (zh) 结合人her2的抗体、其制备方法和用途
JP2014515600A5 (https=)
CN108025064A (zh) 抗磷脂酰肌醇蛋白聚糖-3抗体和其用于诊断与治疗癌症的用途